Search

Simulations Plus Inc

Cerrado

SectorSanidad

18.48

Resumen

Variación precio

24h

Actual

Mínimo

18.48

Máximo

18.48

Métricas clave

By Trading Economics

Ingresos

-960K

3.6M

Ventas

-2.4M

22M

P/B

Media del Sector

46.2

56.254

BPA

0.3

Margen de beneficios

16.335

Empleados

212

EBITDA

-6.3M

1.1M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-13.51% downside

Dividendos

By Acuity

Próximas Ganancias

30 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.6M

374M

Apertura anterior

18.48

Cierre anterior

18.48

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

104 / 340 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 oct 2026, 23:55 UTC

Social Media
News
Correlated Moves

KKR & Co Inc will acquire Gen II Fund Services, LLC for $5.1 billion, with shares modestly higher in after-market trading following the announcement.

5 oct 2026, 23:51 UTC

Social Media
News

Mattel Inc is trading higher in after-hours following Ariel Investments' call for strategic alternatives and reports of a potential offer valuing shares over $20.

5 oct 2026, 23:51 UTC

News
Macro News

Bitcoin is trading lower as Strive announced a $169 million acquisition of 2k BTC, increasing its total holdings to 29.46k BTC.

5 oct 2026, 23:50 UTC

News

DICK'S Sporting Goods shares are modestly lower in after-market trading following a class action lawsuit filed by Levi & Korsinsky, LLP, over alleged false statements.

5 oct 2026, 23:46 UTC

News

F&G Annuities & Life projects third-quarter investment income of $47M to $57M pre-tax, below expectations, while shares rise slightly in after-market trading.

5 oct 2026, 23:46 UTC

News

The USD/CZK is trading modestly higher as the Euro declines against the U.S. dollar amid rising Treasury yields and economic uncertainties in Europe.

5 oct 2026, 23:35 UTC

News
Social Media

Northrop Grumman Corp has received a $66 million contract for engineering retrofit work on MQ-4C Triton systems, with shares trading roughly flat in after-market hours.

5 oct 2026, 23:35 UTC

News

FMC Corp traded modestly lower in after-market hours as UBS reduced its price target to $10 while maintaining a Neutral rating.

5 oct 2026, 23:30 UTC

News

Emergent BioSolutions Inc's stock rises in after-market trading, driven by increased interest in vaccine stocks amid concerns over a suspected plague outbreak in Russia.

5 oct 2026, 23:30 UTC

Social Media
News

Ovid Therapeutics shares rise in after-market hours following Guggenheim's initiation of coverage with a Buy rating and a $7.00 price target.

5 oct 2026, 23:25 UTC

News

Fidelity National Financial shares are modestly higher in after-market trading following the announcement of its third quarter 2026 earnings release date.

5 oct 2026, 23:21 UTC

News

Cleveland-Cliffs shares rise in after-market trading as the company prepares to showcase its $200 million GOES expansion project with U.S. Secretary of Energy on October 6.

5 oct 2026, 23:21 UTC

News

Cabaletta Bio Inc. granted inducement equity awards for 385k shares to new hires, contributing to a higher stock price in after-market trading.

5 oct 2026, 23:06 UTC

News

Snap Inc. saw increased bullish options activity with a put/call ratio of 0.26, while shares traded flat in after-market hours.

5 oct 2026, 23:06 UTC

News

USD/NOK is trading lower following U.S. ISM non-manufacturing new orders data for September, which fell short of forecasts at 59.8.

5 oct 2026, 23:05 UTC

News

Skyworks Solutions shares are declining in after-market trading despite Citi raising the price target to $90.00 from $64.00 while maintaining a Neutral rating.

5 oct 2026, 23:05 UTC

News

Pinterest Inc. appointed James Dibbo as Chief Financial Officer, effective October 26, 2026, with shares trading modestly higher in after-market hours.

5 oct 2026, 23:05 UTC

News

PG&E Corp shares rose in after-market trading, with calls outpacing puts and a low put/call ratio of 0.11 ahead of upcoming earnings.

5 oct 2026, 23:05 UTC

News

Liquidia Corp shares declined in after-market hours following a court ruling that found its product Yutrepia infringed on patents held by United Therapeutics.

5 oct 2026, 23:05 UTC

News
Event

Citi raised its price target on Natera Inc to $480 from $365, maintaining a Buy rating amid growth in its Signatera product and health segments.

5 oct 2026, 23:01 UTC

News

NeoGenomics shares declined in after-market trading following the announcement of a leadership transition and preliminary Q3 revenue expectations of approximately $209 million.

5 oct 2026, 23:01 UTC

News

Fiserv Inc shares traded modestly lower in after-market hours, fluctuating amid pressure ahead of its third-quarter financial results announcement on November 3, 2026.

5 oct 2026, 23:01 UTC

News

Modine Manufacturing Co is higher in after-market trading following Baird's initiation of coverage with an Outperform rating and a price target of $300.00.

5 oct 2026, 23:01 UTC

News

Dynex Capital Inc. will release its third-quarter 2026 financial results on October 19, contributing to a modest increase in after-market trading.

5 oct 2026, 23:01 UTC

News
Social Media
Event

Vaxcyte Inc announced $1 billion in dual public offerings for common stock and convertible notes, leading to a significant decline in after-market trading.

5 oct 2026, 23:00 UTC

News

Freshworks Inc. will join the S&P SmallCap 600 index on October 8, contributing to a higher after-market trading session for the stock.

5 oct 2026, 23:00 UTC

News

BWX Technologies, Inc. advances in after-market trading following selection for a Transportable Nuclear Power Plant project in New Brunswick, aiming for 50 megawatts of electricity.

5 oct 2026, 23:00 UTC

Social Media
News

AbbVie Inc. updated its Q3 adjusted diluted EPS guidance to $3.73-$3.77, while revising 2026 full-year guidance down to $13.76-$13.96; shares were roughly flat in after-market trading.

5 oct 2026, 22:51 UTC

Social Media
News

Lucid Group Inc reported third-quarter production of 2.95k vehicles and deliveries of 3.81k, missing analyst expectations, leading to a decline in after-market hours.

5 oct 2026, 22:15 UTC

News

Repligen Corp plans to acquire BioLife Solutions, contributing to a modest after-market hours gain as the stock remains above its 20-day moving average.

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

-13.51% descenso

Estimación a 12 Meses

Media 16 USD  -13.51%

Máximo 16 USD

Mínimo 16 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

2 ratings

0

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

104 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.